Skip to main content
Thorax logoLink to Thorax
. 1996 Oct;51(10):977–980. doi: 10.1136/thx.51.10.977

Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction.

P Zanen 1, L T Go 1, J W Lammers 1
PMCID: PMC472643  PMID: 8977595

Abstract

BACKGROUND: The optimal particle size of a beta 2 agonist or anticholinergic aerosol in patients with severe airflow obstruction is unknown. METHODS: Seven stable patients with a mean forced expiratory volume in one second (FEV1) of 37.9% of the predicted value inhaled three types of monodisperse salbutamol and ipratropium bromide aerosols with particle sizes of 1.5 microns, 2.8 microns, and 5 microns, respectively, and a placebo aerosol. The volunteers inhaled 20 micrograms salbutamol and 8 micrograms ipratropium bromide, after which lung function changes were determined and analysed with repeated measurements analysis of variance (ANOVA). RESULTS: Greater improvements in FEV1, specific airway conductance (sGaw) and maximum expiratory flow at 75%/50% of the forced vital capacity (MEF75/50) were induced by the 2.8 microns aerosol than by the other particle sizes. CONCLUSIONS: In patients with severe airflow obstruction the particle size of choice for a beta 2 agonist or anticholinergic aerosol should be approximately 3 microns.

Full text

PDF
980

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson P. J., Wilson J. D., Hiller F. C. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest. 1990 May;97(5):1115–1120. doi: 10.1378/chest.97.5.1115. [DOI] [PubMed] [Google Scholar]
  2. Lippmann M., Yeates D. B., Albert R. E. Deposition, retention, and clearance of inhaled particles. Br J Ind Med. 1980 Nov;37(4):337–362. doi: 10.1136/oem.37.4.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Zainudin B. M., Biddiscombe M., Tolfree S. E., Short M., Spiro S. G. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax. 1990 Jun;45(6):469–473. doi: 10.1136/thx.45.6.469. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES